Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Standardized pathological reporting for tumors].
Abbona GC, Papotti M, Montemurro F, Viberti L, Sapino A, Bussolati G. Abbona GC, et al. Among authors: sapino a. Pathologica. 1997 Oct;89(5):546-65. Pathologica. 1997. PMID: 9489404 Italian. No abstract available.
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study.
Sapino A, Montemurro F, Marchiò C, Viale G, Kulka J, Donadio M, Bottini A, Botti G, dei Tos AP, Bersiga A, Di Palma S, Truini M, Sanna G, Aglietta M, Bussolati G. Sapino A, et al. Ann Oncol. 2007 Dec;18(12):1963-8. doi: 10.1093/annonc/mdm417. Epub 2007 Sep 4. Ann Oncol. 2007. PMID: 17785760 Free article.
Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases.
Castellano I, Sapino A, Arisio R, Viale G, Bussolati G, Bandelloni R, Barresi G, Bersiga A, Bordi C, Botti G, Cosimi F, D'Amore E, Doglioni C, Marchetti A, Nappi O, Romeo F, Roncalli M, Russo R, Santinelli A, Spagnoli LG, Tanda F, Tricomi P, Trentini G, Zanconati F, Iurlaro M. Castellano I, et al. Among authors: sapino a. Oncol Rep. 2008 May;19(5):1271-5. Oncol Rep. 2008. PMID: 18425387
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score.
Ménard S, Balsari A, Tagliabue E, Camerini T, Casalini P, Bufalino R, Castiglioni F, Carcangiu ML, Gloghini A, Scalone S, Querzoli P, Lunardi M, Molino A, Mandarà M, Mottolese M, Marandino F, Venturini M, Bighin C, Cancello G, Montagna E, Perrone F, De Matteis A, Sapino A, Donadio M, Battelli N, Santinelli A, Pavesi L, Lanza A, Zito FA, Labriola A, Aiello RA, Caruso M, Zanconati F, Mustacchi G, Barbareschi M, Frisinghelli M, Russo R, Carrillo G; OMERO Group. Ménard S, et al. Among authors: sapino a. Ann Oncol. 2008 Oct;19(10):1706-12. doi: 10.1093/annonc/mdn369. Epub 2008 Jun 9. Ann Oncol. 2008. PMID: 18544559 Free article.
Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.
Montemurro F, Redana S, Viale G, Sanna G, Donadio M, Valabrega G, del Curto B, Bottini A, Botti G, dei Tos AP, Jacomuzzi ME, Di Bonito M, Danese S, Clavarezza M, Kulka J, Di Palma S, Durando A, Sapino A, Aglietta M. Montemurro F, et al. Among authors: sapino a. Clin Breast Cancer. 2008 Oct;8(5):436-42. doi: 10.3816/CBC.2008.n.053. Clin Breast Cancer. 2008. PMID: 18952558
408 results